Seoul Pharma Co. Ltd Strategic Asset Allocation Index
Seoul Pharma Co. Ltd strategic asset allocation index. Seoul Pharma Co. Ltd (018680) has a Strategic Asset Allocation Index of 83.5% as of March 2025. Strategic assets (PP&E of ₩33.40 Billion plus long-term investments of ₩-) total ₩33.40 Billion, measured against net assets of ₩40.01 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Seoul Pharma Co. Ltd (018680) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Seoul Pharma Co. Ltd (2012–2024)
Strategic asset allocation index of Seoul Pharma Co. Ltd from 2012 to 2024. This chart shows how Seoul Pharma Co. Ltd's Strategic Asset Allocation Index has evolved across 13 annual periods from 2012 to 2024. As of March 2025, the index stands at 83.5%, representing strategic assets of ₩33.40 Billion against net assets of ₩40.01 Billion KRW. Check Seoul Pharma Co. Ltd (018680) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Seoul Pharma Co. Ltd Strategic Asset Allocation Index by Year (2012–2024)
Seoul Pharma Co. Ltd strategic asset allocation index by year from 2012 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Seoul Pharma Co. Ltd from 2012 to 2024, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Seoul Pharma Co. Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 84.3% | ₩33.86 Billion | ₩33.86 Billion | ₩- | ₩40.17 Billion | ▲ +3.0 pp |
| 2023 | 81.2% | ₩31.33 Billion | ₩31.33 Billion | ₩- | ₩38.56 Billion | ▼ -5.4 pp |
| 2022 | 86.6% | ₩30.68 Billion | ₩30.68 Billion | ₩- | ₩35.42 Billion | ▼ -93.0 pp |
| 2021 | 179.6% | ₩34.05 Billion | ₩34.05 Billion | ₩- | ₩18.96 Billion | ▲ +56.7 pp |
| 2020 | 123.0% | ₩35.48 Billion | ₩35.48 Billion | ₩- | ₩28.85 Billion | ▼ -22.6 pp |
| 2019 | 145.5% | ₩41.40 Billion | ₩41.40 Billion | ₩- | ₩28.45 Billion | ▲ +62.8 pp |
| 2018 | 82.7% | ₩41.60 Billion | ₩41.28 Billion | ₩319.53 Million | ₩50.31 Billion | ▲ +2.8 pp |
| 2017 | 79.9% | ₩43.04 Billion | ₩42.76 Billion | ₩278.90 Million | ₩53.86 Billion | ▼ -43.6 pp |
| 2016 | 123.5% | ₩51.97 Billion | ₩51.43 Billion | ₩539.40 Million | ₩42.07 Billion | ▼ -19.7 pp |
| 2015 | 143.2% | ₩48.02 Billion | ₩47.52 Billion | ₩493.99 Million | ₩33.53 Billion | ▼ -12.2 pp |
| 2014 | 155.4% | ₩48.32 Billion | ₩47.86 Billion | ₩456.88 Million | ₩31.10 Billion | ▲ +154.1 pp |
| 2013 | 1.3% | ₩421.00 Million | ₩- | ₩421.00 Million | ₩32.25 Billion | ▼ -0.2 pp |
| 2012 | 1.5% | ₩391.00 Million | ₩- | ₩391.00 Million | ₩25.38 Billion | — |